Minimally Invasive Cancer Therapies in Interventional Radiology
description
Transcript of Minimally Invasive Cancer Therapies in Interventional Radiology
![Page 1: Minimally Invasive Cancer Therapies in Interventional Radiology](https://reader036.fdocuments.in/reader036/viewer/2022062315/5681649c550346895dd67dd7/html5/thumbnails/1.jpg)
Minimally Invasive Cancer Therapies in Interventional Radiology
Chief, Vascular and Interventional Radiology
Lancaster Radiology AssociatesCo-Director, Interventional Vascular Unit
![Page 2: Minimally Invasive Cancer Therapies in Interventional Radiology](https://reader036.fdocuments.in/reader036/viewer/2022062315/5681649c550346895dd67dd7/html5/thumbnails/2.jpg)
Objectives
• 1- Identify currently available IR procedures related to cancer care at LGH
• 2- Enhance medical staff knowledge of such procedures
• 3- Discuss current IR cancer treatments
![Page 3: Minimally Invasive Cancer Therapies in Interventional Radiology](https://reader036.fdocuments.in/reader036/viewer/2022062315/5681649c550346895dd67dd7/html5/thumbnails/3.jpg)
Palliative and curative therapies
• Diagnosis• Lung• Genitourinary• Gastrointestinal
![Page 4: Minimally Invasive Cancer Therapies in Interventional Radiology](https://reader036.fdocuments.in/reader036/viewer/2022062315/5681649c550346895dd67dd7/html5/thumbnails/4.jpg)
DIAGNOSIS through Image-Guided Biopsies
• Often one of the initial procedures used to obtain a tissue diagnosis
• Multiple modalities including Computed Tomography, Ultrasound, and Fluoroscopy
• Alone or in combination• Often correlate with PET scan to identify
“active” sites
![Page 5: Minimally Invasive Cancer Therapies in Interventional Radiology](https://reader036.fdocuments.in/reader036/viewer/2022062315/5681649c550346895dd67dd7/html5/thumbnails/5.jpg)
Biopsy Technique
• Often coaxial with “outer” introducer needle and “inner” biopsy needle
• Need a “window”; Want to obtain an adequate tissue sample for diagnosis but need to utilize a safe approach
• May use conscious sedation along with local anesthesia
![Page 6: Minimally Invasive Cancer Therapies in Interventional Radiology](https://reader036.fdocuments.in/reader036/viewer/2022062315/5681649c550346895dd67dd7/html5/thumbnails/6.jpg)
Solitary pulmonary nodule
![Page 7: Minimally Invasive Cancer Therapies in Interventional Radiology](https://reader036.fdocuments.in/reader036/viewer/2022062315/5681649c550346895dd67dd7/html5/thumbnails/7.jpg)
PET scan
![Page 8: Minimally Invasive Cancer Therapies in Interventional Radiology](https://reader036.fdocuments.in/reader036/viewer/2022062315/5681649c550346895dd67dd7/html5/thumbnails/8.jpg)
PET CT fusion
![Page 9: Minimally Invasive Cancer Therapies in Interventional Radiology](https://reader036.fdocuments.in/reader036/viewer/2022062315/5681649c550346895dd67dd7/html5/thumbnails/9.jpg)
CT guided Lung Biopsy
![Page 10: Minimally Invasive Cancer Therapies in Interventional Radiology](https://reader036.fdocuments.in/reader036/viewer/2022062315/5681649c550346895dd67dd7/html5/thumbnails/10.jpg)
Lung Biopsy
![Page 11: Minimally Invasive Cancer Therapies in Interventional Radiology](https://reader036.fdocuments.in/reader036/viewer/2022062315/5681649c550346895dd67dd7/html5/thumbnails/11.jpg)
Ultrasound biopsies
• Require hand-eye coordination• May be used for random sampling, i.e. for
gross liver biopsy• For focal lesions, often in difficult to access
locations, if poorly seen on CT scan, or if lesion is “mobile”
![Page 12: Minimally Invasive Cancer Therapies in Interventional Radiology](https://reader036.fdocuments.in/reader036/viewer/2022062315/5681649c550346895dd67dd7/html5/thumbnails/12.jpg)
Ultrasound guided biopsy of a focal liver mass
![Page 13: Minimally Invasive Cancer Therapies in Interventional Radiology](https://reader036.fdocuments.in/reader036/viewer/2022062315/5681649c550346895dd67dd7/html5/thumbnails/13.jpg)
X-ray guided biopsy
• Especially useful when patient positioning is limited; can rotate and angle the tube to obtain an approach for lesion access
• Advantage of real time imaging
![Page 14: Minimally Invasive Cancer Therapies in Interventional Radiology](https://reader036.fdocuments.in/reader036/viewer/2022062315/5681649c550346895dd67dd7/html5/thumbnails/14.jpg)
Fluoroscopic vertebral body biopsy
![Page 15: Minimally Invasive Cancer Therapies in Interventional Radiology](https://reader036.fdocuments.in/reader036/viewer/2022062315/5681649c550346895dd67dd7/html5/thumbnails/15.jpg)
Rotational angiography and Xper CT
Technology in new Philips angio equipment that combines CT and 3D-imaging.
Enhances IR procedures by allowing you to import previous MRI or CT data and fuse it with angiographic studies.
Allows the interventionalist to use fluoroscopy and apply it to a CT image for challenging access.
![Page 16: Minimally Invasive Cancer Therapies in Interventional Radiology](https://reader036.fdocuments.in/reader036/viewer/2022062315/5681649c550346895dd67dd7/html5/thumbnails/16.jpg)
Planning images
![Page 17: Minimally Invasive Cancer Therapies in Interventional Radiology](https://reader036.fdocuments.in/reader036/viewer/2022062315/5681649c550346895dd67dd7/html5/thumbnails/17.jpg)
Progress images
![Page 18: Minimally Invasive Cancer Therapies in Interventional Radiology](https://reader036.fdocuments.in/reader036/viewer/2022062315/5681649c550346895dd67dd7/html5/thumbnails/18.jpg)
Lung
PalliativeTunneled pleural cathetersThermal ablation of destructive chest wall lesions
CurativeRFA of unresectable lung cancers or lung metastases
![Page 19: Minimally Invasive Cancer Therapies in Interventional Radiology](https://reader036.fdocuments.in/reader036/viewer/2022062315/5681649c550346895dd67dd7/html5/thumbnails/19.jpg)
Tunneled pleural catheter
![Page 20: Minimally Invasive Cancer Therapies in Interventional Radiology](https://reader036.fdocuments.in/reader036/viewer/2022062315/5681649c550346895dd67dd7/html5/thumbnails/20.jpg)
Painful Chest Wall Tumors
![Page 21: Minimally Invasive Cancer Therapies in Interventional Radiology](https://reader036.fdocuments.in/reader036/viewer/2022062315/5681649c550346895dd67dd7/html5/thumbnails/21.jpg)
RFA
![Page 22: Minimally Invasive Cancer Therapies in Interventional Radiology](https://reader036.fdocuments.in/reader036/viewer/2022062315/5681649c550346895dd67dd7/html5/thumbnails/22.jpg)
RFA lung cancer
• Early NSCLC or metastases in those deemed NOT to be surgical candidates
• Could have a poor functional status, abnormal PFTs’, Octogenarians? etc.
• Relapse in Radiation field• Painful bone metastasis• Chest wall invasion
![Page 23: Minimally Invasive Cancer Therapies in Interventional Radiology](https://reader036.fdocuments.in/reader036/viewer/2022062315/5681649c550346895dd67dd7/html5/thumbnails/23.jpg)
RFA lung cancer
![Page 24: Minimally Invasive Cancer Therapies in Interventional Radiology](https://reader036.fdocuments.in/reader036/viewer/2022062315/5681649c550346895dd67dd7/html5/thumbnails/24.jpg)
Lung Cancer survival
• If untreated, median survival 9-12 months.• Surgical resection 5 year 60-70%• RFA or Radiation 5 year 30-50%
• RFA 1 yr: 83-90%; 2 year 48-83%
![Page 25: Minimally Invasive Cancer Therapies in Interventional Radiology](https://reader036.fdocuments.in/reader036/viewer/2022062315/5681649c550346895dd67dd7/html5/thumbnails/25.jpg)
LGH statistics
• 20 tumors treated with RFA; 16 patients.• Treatment goals met in 15/16 patients. All but
one patient was treated for cure. • 4/16 patients required an additional ablation.• Stable or without recurrence for up to 26
months.• 1 unrelated death two days after treatment.
Cardiac arrest.
![Page 26: Minimally Invasive Cancer Therapies in Interventional Radiology](https://reader036.fdocuments.in/reader036/viewer/2022062315/5681649c550346895dd67dd7/html5/thumbnails/26.jpg)
Genitourinary (GU)
• Palliative– Percutanous nephrostomy– Dialysis catheters– Fistula or hemodialysis access maintenance
• Curative– Thermal ablation of renal cell cancer
![Page 27: Minimally Invasive Cancer Therapies in Interventional Radiology](https://reader036.fdocuments.in/reader036/viewer/2022062315/5681649c550346895dd67dd7/html5/thumbnails/27.jpg)
GU procedures
• Percutaneous access to the collecting system for benign or malignant obstructions, stone disease, or urosepsis
• Can place internal double J ureteral stents from percutaneous access
• Can provide access for future stone removal and/or manipulation
![Page 28: Minimally Invasive Cancer Therapies in Interventional Radiology](https://reader036.fdocuments.in/reader036/viewer/2022062315/5681649c550346895dd67dd7/html5/thumbnails/28.jpg)
Percutaneous Nephrostomy
![Page 29: Minimally Invasive Cancer Therapies in Interventional Radiology](https://reader036.fdocuments.in/reader036/viewer/2022062315/5681649c550346895dd67dd7/html5/thumbnails/29.jpg)
PCN
![Page 30: Minimally Invasive Cancer Therapies in Interventional Radiology](https://reader036.fdocuments.in/reader036/viewer/2022062315/5681649c550346895dd67dd7/html5/thumbnails/30.jpg)
Hemodialysis Catheter
![Page 31: Minimally Invasive Cancer Therapies in Interventional Radiology](https://reader036.fdocuments.in/reader036/viewer/2022062315/5681649c550346895dd67dd7/html5/thumbnails/31.jpg)
Fistula
![Page 32: Minimally Invasive Cancer Therapies in Interventional Radiology](https://reader036.fdocuments.in/reader036/viewer/2022062315/5681649c550346895dd67dd7/html5/thumbnails/32.jpg)
Cryoablation of Renal Cancer
![Page 33: Minimally Invasive Cancer Therapies in Interventional Radiology](https://reader036.fdocuments.in/reader036/viewer/2022062315/5681649c550346895dd67dd7/html5/thumbnails/33.jpg)
CT cryoablation
![Page 34: Minimally Invasive Cancer Therapies in Interventional Radiology](https://reader036.fdocuments.in/reader036/viewer/2022062315/5681649c550346895dd67dd7/html5/thumbnails/34.jpg)
Cryoablation
• Argon gas for freezing; Helium for thawing.• Multiple probes; RFA just a single probe.• Less risk of damage to collecting system.• Greater risk of bleeding compared with RFA
(coagulative necrosis).• -20 to -40 degrees Celsius. Cell death.• Can better identify treated zone.
![Page 35: Minimally Invasive Cancer Therapies in Interventional Radiology](https://reader036.fdocuments.in/reader036/viewer/2022062315/5681649c550346895dd67dd7/html5/thumbnails/35.jpg)
Survival
• Stage I RCC- surgery with partial nephrectomy or nephrectomy 80+% 5 year survival
• Difficult to do much better for early disease• Stage I RCC treated with RFA for 3 cm tumors
or smaller 94% 2 year survival. Decreased survival as tumor size increases beyond 3 cm.
![Page 36: Minimally Invasive Cancer Therapies in Interventional Radiology](https://reader036.fdocuments.in/reader036/viewer/2022062315/5681649c550346895dd67dd7/html5/thumbnails/36.jpg)
36
Is RCC Cryoablation Effective?
1 Littrup, J Vasc Interv Radiol 2007; Atwell, J Urol 2010; Rodriguez, Cardiovasc Interv Radiol 2011
Littrup Atwell Rodriguez89%
90%
91%
92%
93%
94%
95%
96%
97%
98%
92%
94%
98%
Efficacy
Series 1
Loca
l Tum
or C
ontr
ol A
fter
One
Cry
oabl
ation
Tre
atm
ent
19 months 26 months 24 months
![Page 37: Minimally Invasive Cancer Therapies in Interventional Radiology](https://reader036.fdocuments.in/reader036/viewer/2022062315/5681649c550346895dd67dd7/html5/thumbnails/37.jpg)
LGH statistics
• 7 tumors treated• 6/7 Renal cell cancer. 1/7 benign oncocytoma.• 6/7 no signs of recurrence. 1/7 partially
treated and opted for surveillance.
![Page 38: Minimally Invasive Cancer Therapies in Interventional Radiology](https://reader036.fdocuments.in/reader036/viewer/2022062315/5681649c550346895dd67dd7/html5/thumbnails/38.jpg)
Gastrointestinal (GI)
• Palliative– Peritoneal catheters– Gastric tubes– Cholecystostomy drains– Biliary stents
• Locoregional control– Catheter-based embolization– Percutaneous thermal ablation
![Page 39: Minimally Invasive Cancer Therapies in Interventional Radiology](https://reader036.fdocuments.in/reader036/viewer/2022062315/5681649c550346895dd67dd7/html5/thumbnails/39.jpg)
Peritoneal Catheter
![Page 40: Minimally Invasive Cancer Therapies in Interventional Radiology](https://reader036.fdocuments.in/reader036/viewer/2022062315/5681649c550346895dd67dd7/html5/thumbnails/40.jpg)
Percutaneous Gastrostomy
![Page 41: Minimally Invasive Cancer Therapies in Interventional Radiology](https://reader036.fdocuments.in/reader036/viewer/2022062315/5681649c550346895dd67dd7/html5/thumbnails/41.jpg)
Acute Cholecystitis
![Page 42: Minimally Invasive Cancer Therapies in Interventional Radiology](https://reader036.fdocuments.in/reader036/viewer/2022062315/5681649c550346895dd67dd7/html5/thumbnails/42.jpg)
Percutaneous Cholecystostomy
![Page 43: Minimally Invasive Cancer Therapies in Interventional Radiology](https://reader036.fdocuments.in/reader036/viewer/2022062315/5681649c550346895dd67dd7/html5/thumbnails/43.jpg)
Biliary Obstruction
![Page 44: Minimally Invasive Cancer Therapies in Interventional Radiology](https://reader036.fdocuments.in/reader036/viewer/2022062315/5681649c550346895dd67dd7/html5/thumbnails/44.jpg)
Biliary Wallstent
![Page 45: Minimally Invasive Cancer Therapies in Interventional Radiology](https://reader036.fdocuments.in/reader036/viewer/2022062315/5681649c550346895dd67dd7/html5/thumbnails/45.jpg)
Unresectable Liver
Dominant
Image-Guided Therapy for Hepatic Malignancies
![Page 46: Minimally Invasive Cancer Therapies in Interventional Radiology](https://reader036.fdocuments.in/reader036/viewer/2022062315/5681649c550346895dd67dd7/html5/thumbnails/46.jpg)
Definitions
• Liver-dominant neoplasm: malignancy in which the hepatic component is the only site of disease or the dominant site most likely to lead to patient morbidity or mortality
![Page 47: Minimally Invasive Cancer Therapies in Interventional Radiology](https://reader036.fdocuments.in/reader036/viewer/2022062315/5681649c550346895dd67dd7/html5/thumbnails/47.jpg)
What’s so good about embolization or chemoembolization?
• Minimally-invasive loco-regional treatment• Spares the patient the morbidity of surgery,
radiation, or systemic therapy• Achieves tumor necrosis• Increases drug concentration delivered and
dwell time of agent(s)• Decreases systemic toxicity
![Page 48: Minimally Invasive Cancer Therapies in Interventional Radiology](https://reader036.fdocuments.in/reader036/viewer/2022062315/5681649c550346895dd67dd7/html5/thumbnails/48.jpg)
Definitions
• Embolization: refers to blocking arteries by particles alone
• Oily Chemoembolization: infusion of chemotherapeutic agents with Ethiodized oil followed by embolic agents
• Drug-eluting beads: chemoembolization with calibrated microspheres that release drug over time
![Page 49: Minimally Invasive Cancer Therapies in Interventional Radiology](https://reader036.fdocuments.in/reader036/viewer/2022062315/5681649c550346895dd67dd7/html5/thumbnails/49.jpg)
Definitions
• Tumor Ablation: direct application of thermal or chemical therapies to tumor(s) to eradicate or substantially destroy it– Chemical: ethanol or acetic acid– Thermal: application of energy to cause tumor
necrosis. Examples include radiofrequency ablation (RFA), microwave, cryotherapy, high-intensity focused ultrasound (HIFU)
![Page 50: Minimally Invasive Cancer Therapies in Interventional Radiology](https://reader036.fdocuments.in/reader036/viewer/2022062315/5681649c550346895dd67dd7/html5/thumbnails/50.jpg)
Why consider tumor ablation?
• Patients are living longer and presenting later in life with cancer.
• Co-morbid conditions are a major factor in considering patients for surgical resection.
• Minimally invasive therapies are in demand.• Tumor ablation offers a chance for cure without
surgery.• Important psychological benefits to patients
instead of just waiting and seeing what happens.
![Page 51: Minimally Invasive Cancer Therapies in Interventional Radiology](https://reader036.fdocuments.in/reader036/viewer/2022062315/5681649c550346895dd67dd7/html5/thumbnails/51.jpg)
Hepatocellular Carcinoma
• Fewer than 20% of patients are candidates for resection due to cirrhosis.
• Transplantation only curative option for those with limited disease (one tumor < 5 cm, or three tumors < 3 cm).
• Choice of therapy depends on overall size, number, and location of tumors.
![Page 52: Minimally Invasive Cancer Therapies in Interventional Radiology](https://reader036.fdocuments.in/reader036/viewer/2022062315/5681649c550346895dd67dd7/html5/thumbnails/52.jpg)
Chemoembolization of HCC: Randomized Trials
1) Lo et al., Hepatology 200280 Patients, 80% hep. B +, 7 cm tumors (60% multifocal)TACE Supportive care57, 31, 26% 32, 11, 3% (1, 2, 3 year survival)
2) Llovet et al., Lancet 2002 112 Patients, 80-90% hep. C +, 5 cm tumors (70% multifocal)
TACE Supportive care82, 63% 63, 27% (1, 2 year survival)
![Page 53: Minimally Invasive Cancer Therapies in Interventional Radiology](https://reader036.fdocuments.in/reader036/viewer/2022062315/5681649c550346895dd67dd7/html5/thumbnails/53.jpg)
surgery
resectable
<2cmimage q3 months
>2cmembo/ablate
image q3 months
OLT candidate1 tumor ² 5cm
2-3 tumors ²3cm
<3 cm ablate3-8 cm embo/ablate
>8cm embosorafenib?
Childs A/BBCLC A-C
PS 0-2Labs OK
death talksorafenib?
Childs COkuda 3PS 3-4
bad labs
Not Surgical Candidate
Hepatoma
Hepatoma
![Page 54: Minimally Invasive Cancer Therapies in Interventional Radiology](https://reader036.fdocuments.in/reader036/viewer/2022062315/5681649c550346895dd67dd7/html5/thumbnails/54.jpg)
Colorectal Metastases
• Median Survival for untreated 6-13 months• Survival for most effective chemotherapy is 20
months• Resecting metastases increases 5-year survival
from 0-1% to 31-58%, perhaps even higher, more recent studies suggest.
• Only 5-20% eligible for surgical resection.
![Page 55: Minimally Invasive Cancer Therapies in Interventional Radiology](https://reader036.fdocuments.in/reader036/viewer/2022062315/5681649c550346895dd67dd7/html5/thumbnails/55.jpg)
COLON CANCERChemoembolization: Phase II Trials
BCLC NWU U Penn1 Frankfurt2
#PTS 40 30 120 463Disease Control 63% 63% 43% 63%Med. Surv. 24 mo. 29 mo. 27 mo. 38
mo.iology 2009
![Page 56: Minimally Invasive Cancer Therapies in Interventional Radiology](https://reader036.fdocuments.in/reader036/viewer/2022062315/5681649c550346895dd67dd7/html5/thumbnails/56.jpg)
Colorectal mets and RF ablation
• RF ablation useful in patients not eligible for surgical resection, however, multiple independent studies showed that survival rates approach those of surgical resection.
• Local control best achieved in tumors 3.5 cm in size or smaller; goal of RFA is achieve a 1-cm ablation zone.
• RFA mortality is < 0.5% compared with 17-37% for surgical resection.
![Page 57: Minimally Invasive Cancer Therapies in Interventional Radiology](https://reader036.fdocuments.in/reader036/viewer/2022062315/5681649c550346895dd67dd7/html5/thumbnails/57.jpg)
Colorectal Metastases
[3-6 months chemo]resect
Resectable
<3 cm ablate3-6 cm embo/ablate
>6 cm embosystemic
liver dominantunresectable
labs and PS OK
systemic
not liver dominantOR
contraindication to embo
Colon Mets
![Page 58: Minimally Invasive Cancer Therapies in Interventional Radiology](https://reader036.fdocuments.in/reader036/viewer/2022062315/5681649c550346895dd67dd7/html5/thumbnails/58.jpg)
Neuroendocrine Tumors
• Only 5% of carcinoid tumors• Up to 90% of gastrinomas• Patients can be plagued by unregulated
hormonal secretions of their tumors.• Control with somatostatin agents.• Those with hormonal production often have
bulk liver disease, a contraindication to surgery.
![Page 59: Minimally Invasive Cancer Therapies in Interventional Radiology](https://reader036.fdocuments.in/reader036/viewer/2022062315/5681649c550346895dd67dd7/html5/thumbnails/59.jpg)
NET
clinic/labs/imagingq 3-6 months
No sx on Sandostain-LARLFTs normal
tumor burden <50%
resectablesurgery
unresectableembo
[ablate]
Sx despite SandostatinOR abnl LFTs
OR tumor burden 50%
Liver dominant
palliative embo
systemic rx
Not liver dominant
NET
![Page 60: Minimally Invasive Cancer Therapies in Interventional Radiology](https://reader036.fdocuments.in/reader036/viewer/2022062315/5681649c550346895dd67dd7/html5/thumbnails/60.jpg)
Summary• Interventional Radiology has a critical role in the care of cancer
patients and offers both palliative and curative therapies.• Although many of these therapies are not first line treatment,
they should not be considered rescue therapy either. Rather, these interventions should be considered routinely during the evaluation and management of the cancer patient.
• There is increasing evidence to support improved survival and improved quality of life with combination therapies; for example, ablation with adjuvant chemotherapy, or chemoembolization with adjuvant radiation therapy.
![Page 61: Minimally Invasive Cancer Therapies in Interventional Radiology](https://reader036.fdocuments.in/reader036/viewer/2022062315/5681649c550346895dd67dd7/html5/thumbnails/61.jpg)
Thank you
• Lancaster Radiology Associates 299-4173• Interventional Radiology 544-4929• Consultations through Centralized Scheduling
at 544-5941.